1. Home
  2. BBAR vs ZLAB Comparison

BBAR vs ZLAB Comparison

Compare BBAR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco BBVA Argentina S.A. ADS

BBAR

Banco BBVA Argentina S.A. ADS

N/A

Current Price

$14.55

Market Cap

3.0B

Sector

Finance

ML Signal

N/A

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$25.02

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBAR
ZLAB
Founded
1886
2013
Country
Argentina
China
Employees
6493
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
BBAR
ZLAB
Price
$14.55
$25.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$17.00
$49.60
AVG Volume (30 Days)
832.9K
923.4K
Earning Date
05-20-2026
05-07-2026
Dividend Yield
2.04%
N/A
EPS Growth
N/A
38.46
EPS
N/A
N/A
Revenue
N/A
$460,156,000.00
Revenue This Year
$18.32
$9.75
Revenue Next Year
$11.04
$26.03
P/E Ratio
$26.78
N/A
Revenue Growth
N/A
15.33
52 Week Low
$7.76
$15.96
52 Week High
$22.47
$34.72

Technical Indicators

Market Signals
Indicator
BBAR
ZLAB
Relative Strength Index (RSI) 38.50 51.52
Support Level $13.43 $16.84
Resistance Level $15.68 $25.28
Average True Range (ATR) 0.71 0.79
MACD 0.12 -0.42
Stochastic Oscillator 26.32 30.05

Price Performance

Historical Comparison
BBAR
ZLAB

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: